Table of Contents page: Journal of Cystic Fibrosis

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Editorial Board

Published in issue: March 2023

ii

Full length article

Fundamental and translational research in Cystic Fibrosis – why we still need it

Carlos M. Farinha,
Jeffrey L. Brodsky,
Nicoletta Pedemonte

Published online: December 26, 2022

S1-S4

Open Access

Structure basis of CFTR folding, function and pharmacology

Tzyh-Chang Hwang,
Ineke Braakman,
Peter van der Sluijs,
Isabelle Callebaut

Published online: October 07, 2022

S5-S11

Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy

Alessandra Ghigo,
Chiara De Santi,
Merrill Hart,
Nilay Mitash,
Agnieszka Swiatecka-Urban

Published online: January 06, 2023

S12-S16

CFTR-beyond the airways: Recent findings on the role of the CFTR channel in the pancreas, the intestine and the kidneys

Peter Hegyi,
Ursula Seidler,
Karl Kunzelmann

Published online: January 06, 2023

S17-S22

Restoring airway epithelial homeostasis in Cystic Fibrosis

Marco Cafora,
Marc Chanson,
Anna Pistocchi

Published online: October 07, 2022

S27-S31

Patient-derived cell models for personalized medicine approaches in cystic fibrosis

Anabela S. Ramalho,
Felice Amato,
Martina Gentzsch

Published online: December 16, 2022

S32-S38

Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis

Normand E. Allaire,
Uta Griesenbach,
Batsheva Kerem,
John D. Lueck,
Noemie Stanleigh,
Yifat S. Oren

Published online: January 17, 2023

S39-S44

Development of novel therapeutics for all individuals with CF (the future goes on)

Margarida D. Amaral,
Patrick T. Harrison

Published online: October 30, 2022

S45-S49

Review article

Mucus aberrant properties in CF: Insights from cells and animal models

Camille Ehre,
Gunnar C. Hansson,
David J. Thornton,
Lynda S. Ostedgaard

Published online: September 15, 2022

S23-S26

Latest

Popular Articles

ECFS best practice guidelines: the 2018 revision

Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del

Pancreatic insufficiency in Cystic Fibrosis

Latest Articles

News article

Early Glucose abnormalities in cystic fibrosis – how best to measure them, and what is to be done about them?

Newborn screening for CF – The good, the bad and the ugly

For Authors

Society

Journal Information

Access

Contact

Follow Us

March 2023

Editorial Board

Editorial Board

Full length article

Fundamental and translational research in Cystic Fibrosis – why we still need it

Structure basis of CFTR folding, function and pharmacology

Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy

CFTR-beyond the airways: Recent findings on the role of the CFTR channel in the pancreas, the intestine and the kidneys

Restoring airway epithelial homeostasis in Cystic Fibrosis

Patient-derived cell models for personalized medicine approaches in cystic fibrosis

Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis

Development of novel therapeutics for all individuals with CF (the future goes on)

Review article

Mucus aberrant properties in CF: Insights from cells and animal models